Neogene Therapeutics is a pre-clinical stage biotechnology company aiming to change the paradigm of treatment for solid cancers. Our mission is to provide cancer patients with T cell therapies targeting mutated proteins called neo-antigens, which are present on cancer cells as a consequence of DNA mutations. Neogene is developing novel technologies to enable the engineering of ‘designer T cells’ with neo-antigen specificities that display an optimized ability to seek and destroy cancer cells.
For our R&D department in Amsterdam, we are seeking a highly motivated individual to join our T cell engineering research team as a (Senior) Research Associate. The individual will embrace state-of-the-art genome editing tools to enhance the potency and clinical efficacy of neo-antigen–based T cell therapies.
Responsibilities include, but are not limited to:
We offer the opportunity to join a highly dynamic growth-stage biotech company. You can expect a collaborative environment created by a team with deep scientific expertise and an industrial track-record in T cell therapies. We value pro-active team-players who pursue their goals with dedication, endurance and a daring mindset. If you share our commitment to make a difference to patients in need, we can provide a unique opportunity to be a major contributor to the success of a well-positioned, well-financed growth-stage biotechnology company.
If you are interested, please submit your electronic application including cover letter and CV to firstname.lastname@example.org
No recruiters. No phone calls.